共查询到20条相似文献,搜索用时 15 毫秒
1.
Jacob E. Earp Robert U. Newton Prue Cormie Anthony J. Blazevich 《European journal of applied physiology》2014,114(1):59-69
Tendon stiffness increases as the magnitude and rate of loading increases, according to its viscoelastic properties. Thus, under some loading conditions tendons should become exceptionally stiff and act almost as rigid force transducers. Nonetheless, observations of tendon behavior during multi-joint sprinting and jumping tasks have shown that tendon strain increases whilst muscle strain decreases as the loading intensity increases. The purpose of the current study was to examine the influence of external loading intensity on muscle–tendon unit (MTU) behavior during a high-speed single-joint, stretch-shortening cycle (SSC) knee extension task. Eighteen men (n = 9) and women (n = 9) performed single-leg, maximum intensity SSC knee extensions at loads of 20, 60 and 90?% of their one repetition maximum. Vastus lateralis fascicle length (L f) and velocity (v f) as well as MTU (L MTU) and tendinous tissue (L t) length were measured using high-speed ultrasonography (96 Hz). Patellar tendon force (F t) and rate of force development (RFDt) were estimated using inverse dynamics. Results showed that as loading intensity increased, concentric joint velocity and shortening v f decreased whilst F t and RFDt increased, but no significant differences were observed in eccentric joint velocity or peak L MTU or L f. In addition, the tendon lengthened significantly less at the end of the eccentric phase at heavier loads. This is the first observation that tendon strain decreases significantly during a SSC movement as loading intensity increases in vivo, resulting in a shift in the tendon acting as a power amplifier at light loads to a more rigid force transducer at heavy loads. 相似文献
2.
Steady-state conditions of contraction, at maximal and submaximal forces, were produced in intact single muscle fibres, from Rana esculenta, using full tetani and graded K+-contractures. The uniformity in radial direction, of spreading of activation produced in K+-contractures, was checked in relation to the fibre diameters. The absolute isometric force was similar in tetani and maximal contractures, for fibres with diameters between 40 and 60 m, but not for fibres with diameters greater than about 70 m in which contracture force never reached tetanic force. The force–[K+]o relation was similar for fibres with diameters between 40 and 60 m, but it was right shifted and it had a minor slope for fibres with diameters greater than 65–70 m. This suggests that only in the small diameter fibres (40–60 m) the activation does not fail to penetrate uniformly from the surface towards the fibre core. For fibres selected in the diameter range between 40 and 60 m, force–velocity relations and unloaded shortening velocities were determined in tetani and maximal and submaximal contractures. Data were obtained across a force range of 0.3 to 1 P
0 (tetanic plateau force). Controlled velocity method was used to obtain force–velocity relations, and slack test to determine the unloaded shortening velocity (V
U). The values of the parameters characterising the force–velocity relation (V
0 and a/P
0) and V
U as determined by the slack test did not differ significantly in tetani and contractures, independent of the activation level or absolute force developed by the fibre. These results show that, at least within the range of forces tested, crossbridge kinetics is independent of the number of cycling crossbridges, in agreement with the prediction of the recruitment model of myofilament activation. 相似文献
3.
Acute and delayed neuromuscular adjustments of the triceps surae muscle group to exhaustive stretch–shortening cycle fatigue 总被引:2,自引:0,他引:2
Stretch–shortening cycle (SSC)-type fatigue is associated with acute and delayed functional defects, and appears to be a useful model to reveal the flexibility of both central and reflex adjustments to the contractile failure. SSC fatigue was induced in an experimental (EXP) group (n=6) on a sledge ergometer with an exhaustive rebound exercise with submaximal effort. The acute (POST) and 2-day delayed (2D) neuromuscular changes with fatigue were examined in a short submaximal rebound task (REBOUND) and in a maximal isometric plantarflexion test (ISOM). The EXP group results were compared to those of a control group (n=6) who did not perform the exhaustive SSC exercise and did not present any change in the tests. In the EXP group, the ISOM test revealed mostly a large decrease in maximal plantarflexion force at 2D that was correlated with the reduced mean soleus muscle (SOL) activation. Indicating task-dependent fatigue effects on the neural changes, the REBOUND test revealed both acute and delayed increases in SOL activation. Supporting central neural changes, SOL preactivation increased in POST and 2D. The neural flexibility along time and across muscles was demonstrated by the shifted increase in SOL activation from the braking phase in POST to the push-off phase in 2D, and associated increased gastrocnemius medialis preactivation in 2D. In contrast, activation during the stretch–reflex period was constant in POST, and decreased in 2D. These results would support the influence of musculotendinous afferents on the flexible neural adjustments to the SSC-induced contractile failure. 相似文献
4.
S. Kamandulis A. Skurvydas N. Masiulis G. Mamkus H. Westerblad 《Acta physiologica (Oxford, England)》2010,198(1):91-98
Aim: Unaccustomed physical exercise with a large eccentric component is accompanied by muscle damage and impaired contractile function, especially at low stimulation frequencies. A repeated bout of eccentric exercise results in less damage and improved recovery of contractile function. Here we test the hypotheses that (1) a prior stretch–shortening cycle (SSC) exercise protects against impaired muscle function during a subsequent bout of SSC exercise and (2) the protection during exercise is transient and becomes less effective as the exercise progresses. Methods: Healthy untrained men (n = 7) performed SSC exercise consisting of 100 maximal drop jumps at 30 s intervals. The same exercise was repeated 4 weeks later. Peak quadriceps muscle force evoked by electrical stimulation at 15 (P15) and 50 (P50) Hz was measured before exercise, after 10, 25, 50 and 100 jumps as well as 1 and 24 h after exercise. Results: P15 and P50 were higher during the initial phase of the repeated bout compared with the first exercise bout, but there was no difference between the bouts at the end of the exercise periods. P15 and P50 were again larger 24 h after the repeated bout. The P15/P50 ratio during exercise was not different between the two bouts, but it was higher after the repeated bout. Conclusion: A prior bout of SSC exercise temporarily protects against impaired contractile function during a repeated exercise bout. The protection can again be seen after exercise, but the underlying mechanism then seems to be different. 相似文献
5.
Marsh DR Carson JA Stewart LN Booth FW 《Journal of muscle research and cell motility》1998,19(8):897-907
Little is known conerning promoter regulation of genes in regenerating skeletal muscles. In young rats, recovery of muscle mass and protein content is complete within 21 days. During the initial 5–10 days of regeneration, mRNA abundance for IGF-I, myogenin and MyoD have been shown to be dramatically increased. The skeletal -actin promoter contains E box and serum response element (SRE) regulatory regions which are directly or indirectly activated by myogenin (or MyoD) and IGF-I proteins, respectively. We hypothesized that the skeletal -actin promoter activity would increase during muscle regeneration, and that this induction would occur before muscle protein content returned to normal. Total protein content and the percentage content of skeletal -actin protein was diminished at 4 and 8 days and re-accumulation had largely occurred by 16 days post-bupivacaine injection. Skeletal - actin mRNA per whole muscle was decreased at day 8, and thereafter returned to control values. During regeneration at day 8, luciferase activity (a reporter of promoter activity) directed by –424 skeletal -actin and –99 skeletal -actin promoter constructs was increased by 700% and 250% respectively; however, at day 16, skeletal -actin promoter activities were similar to control values. Thus, initial activation of the skeletal - actin promoter is associated with regeneration of skeletal muscle, despite not being sustained during the later stages of regrowth. The proximal SRE of the skeletal -actin promoter was not sufficient to confer a regeneration-induced promoter activation, despite increased serum response factor protein binding to this regulatory element in electrophoretic mobility shift assays. Skeletal -actin promoter induction during regeneration is due to a combination of regulatory elements, at least including the SRE and E box. © Kluwer Academic Publishers. 相似文献
6.
Excitability of the soleus reflex arc during intensive stretch–shortening cycle exercise in two power-trained athlete groups 总被引:2,自引:2,他引:0
In several explosive types of sport events the leg extensor muscles are subjected to very high impact loads. Thus, extreme requirements exist for the neuromuscular system to develop sufficient muscle stiffness in the lower extremities in order to tolerate these high impact loads. Therefore, it would be challenging to measure reflex modulation during high impact activities, and with different athlete populations. In the present experiment, H-reflex and short latency reflex (M1) sensitivity was measured during drop jump exercises among high jumpers and sprinters. The changes in both reflex peak-to-peak amplitudes showed a significant (P < 0.05) reduction towards the end of the exercise for the sprinters. In addition, the same subject group showed a remarkable increase in serum creatine kinase (CK) activity 2 h after the jumps. Similar changes could not be observed for the high jumpers. These results clearly indicate different neural adaptation strategies for the two athlete groups. Reduction in H-reflex sensitivity and an increase in CK-activity in sprinters were taken as evidence for presynaptic inhibition, probably induced by substances related to muscle damage. Since high jump training includes more high impact loading, it was assumed that it could lead to some structural adaptation and, thus, prevents exercise induced reflex modification to a certain extent. 相似文献
7.
The aim of this study was to investigate the influence of changing elastic properties of tendon and aponeuroses on force production
and muscle geometry. A three-dimensional, structural, continuum mechanics model of the cat medial gastrocnemius was used for
this purpose. Increasing compliance in tendon and aponeuroses caused a decrease in the peak isometric force and a shift of
the force–length relationship to the right of the length axis (i.e. toward greater muscle lengths). This result can be explained
with the stability condition of the force–length relationship which produced a history dependence of force production that
is conceptually in agreement with experimental observations. 相似文献
8.
Watanabe Daiki Lamboley Cedric R. Lamb Graham D. 《Journal of muscle research and cell motility》2020,41(2-3):239-250
Journal of Muscle Research and Cell Motility - This study investigated the effect of S-glutathionylation on passive force in skeletal muscle fibres, to determine whether activity-related redox... 相似文献
9.
The tension rise during stretch of passive skeletal muscle is biphasic, with an initial steep rise, followed by a subsequent more gradual change. The initial rise has been interpreted as being due to the presence of numbers of long-term, stable cross-bridges in resting muscle fibres. A point of weakness with the cross-bridge interpretation is that the initial stiffness reaches its peak value at muscle lengths beyond the optimum for myofilament overlap. To explain this result it has been suggested that despite the reduced overlap at longer lengths, the closer interfilament spacing and a higher sensitivity of the myofilaments to Ca2+ allows more stable cross-bridges to form. Recently the stretch responses of passive muscle have been re-examined and it has been suggested that it is not necessary to invoke cross-bridge mechanisms at all. Explanations based on a viscous resistance to interfilament sliding and mechanical properties of the elastic filaments, the gap filaments, were thought to adequately account for the observed tension changes. However, an important property of passive muscle, the dependence of stretch responses on the immediate history of contraction and length changes, thixotropy, cannot be explained simply in terms of viscous and viscoelastic properties. The review discusses the cross-bridge interpretation of muscle thixotropy and the relationship of passive stiffness to filament resting tension and latency relaxation. It is proposed that cross-bridges can exist in three states; one, responsible for the resting stiffness, requires resting levels of calcium. When, during activation, calcium levels rise, cross-bridges enter a low-force, high-stiffness state, signalled by latency relaxation, before they move to the third, force-generating state. It is concluded that, compared with viscoelastic models, a cross-bridge-based explanation of passive muscle properties is better able to accommodate the currently known facts although, as new information becomes available, this view may need to be revised. 相似文献
10.
In experiments on isolated animal muscle, the force produced during active lengthening contractions can be up to twice the isometric force, whereas in human experiments lengthening force shows only modest, if any, increase in force. The presence of synergist and antagonist muscle activation associated with human experiments in situ may partly account for the difference between animal and human studies. Therefore, this study aimed to quantify the force–velocity relationship of the human soleus muscle and assess the likelihood that co-activation of antagonist muscles was responsible for the inhibition of torque during submaximal voluntary plantar flexor efforts. Seven subjects performed submaximal voluntary lengthening, shortening(at angular, velocities of +5, –5, +15, –15 and +30, and –30° s–1) and isometric plantar flexor efforts against an ankle torque motor. Angle-specific (90°) measures of plantar flexor torque plus surface and intramuscular electromyography from soleus, medial gastrocnemius and tibialis anterior were made. The level of activation (30% of maximal voluntary isometric effort) was maintained by providing direct visual feedback of the soleus electromyogram to the subject. In an attempt to isolate the contribution of soleus to the resultant plantar flexion torque, activation of the synergist and antagonist muscles were minimised by: (1) flexing the knee of the test limb, thereby minimising the activation of gastrocnemius, and (2) applying an anaesthetic block to the common peroneal nerve to eliminate activation of the primary antagonist muscle, tibialis anterior and the synergist muscles, peroneus longus and peroneus brevis. Plantar flexion torque decreased significantly (P<0.05) after blocking the common peroneal nerve which was likely due to abolishing activation of the peroneal muscles which are synergists for plantar flexion. When normalised to the corresponding isometric value, the force–velocity relationship between pre- and post-block conditions was not different. In both conditions, plantar flexion torques during shortening actions were significantly less than the isometric torque and decreased at faster velocities. During lengthening actions, however, plantar flexion torques were not significantly different from isometric regardless of angular velocity. It was concluded that the apparent inhibition of lengthening torques during voluntary activation is not due to co-activation of antagonist muscles. Results are presented as mean (SEM). 相似文献
11.
Hoshino S Ohkoshi N Ishii A Shoji S 《Journal of muscle research and cell motility》2002,23(2):131-138
The expression of α-dystrobrevin and dystrophin in rat tibialis anterior muscles was chronologically evaluated during a cycle
of regeneration after myonecrosis induced by the injection of cardiotoxin. In immunohistochemical studies, α-dystrobrevin
and dystrophin were first stained weakly at the sarcolemma of some regenerating muscle fibers on day 5. On day 7, α-dystrobrevin
was still stained weakly, whereas dystrophin was stained conspicuously. After day 10, α-dystrobrevin and dystrophin were both
stained conspicuously on almost all regenerating muscle fibers. In the Western blot analysis, α-dystrobrevin and dystrophin
were first detected as visible bands on days 5 and 7, respectively. The bands of α-dystrobrevin and dystrophin both darkened
sequentially up to day 10. The protein levels based on the densitometrical analysis of the bands on each day were converted
to the percentage of the protein level on day 28, which was taken as 100%. The sequential line based on these data showed
that α-dystrobrevin and dystrophin reached 50% of the protein level on day 28 by 6.6 and 5.3 days, respectively. These data
provide evidence that α-dystrobrevin regenerates more slowly than dystrophin in skeletal muscle.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
12.
Na+–K+ pump location and translocation during muscle contraction in rat skeletal muscle 总被引:1,自引:0,他引:1
Kristensen M Rasmussen MK Juel C 《Pflügers Archiv : European journal of physiology》2008,456(5):979-989
Muscle contraction may up-regulate the number of Na(+)-K(+) pumps in the plasma membrane by translocation of subunits. Since there is still controversy about where this translocation takes place from and if it takes place at all, the present study used different techniques to characterize the translocation. Electrical stimulation and biotin labeling of rat muscle revealed a 40% and 18% increase in the amounts of the Na(+)-K(+) pump alpha(2) subunit and caveolin-3 (Cav-3), respectively, in the sarcolemma. Exercise induced a 36% and 19% increase in the relative amounts of the alpha(2) subunit and Cav-3, respectively, in an outer-membrane-enriched fraction and a 41% and 17% increase, respectively, in sarcolemma giant vesicles. The Na(+)-K(+) pump activity measured with the 3-O-MFPase assay was increased by 37% in giant vesicles from exercised rats. Immunoprecipitation with Cav-3 antibody showed that 17%, 11% and 14% of the alpha(1) subunits were associated with Cav-3 in soleus, extensor digitorum longus, and mixed muscles, respectively. For the alpha(2), the corresponding values were 17%, 5% and 16%. In conclusion; muscle contraction induces translocation of the alpha subunits, which is suggested to be caused partly by structural changes in caveolae and partly by translocation from an intracellular pool. 相似文献
13.
14.
Hoshino S Ohkoshi N Ishii A Kameya S Takeda S Shoji S 《Journal of muscle research and cell motility》2001,22(2):185-191
The expression of dystrophin and 1-syntrophin in rat tibialis anterior muscles were evaluated during a cycle of regeneration after myonecrosis induced by the injection of cardiotoxin. Immunohistochemical studies were performed in cryosections of muscles on days 1, 3, 5, 7, 10, 14, 21 and 28 after injection of cardiotoxin. Western blot analysis was also examined in muscle on days 1, 3, 5, 7, 10, 14, 21 and 28. In immunohistochemical studies, dystrophin was stained weakly at the sarcolemma of some regenerating muscle fibers on day 3, and by day 10 it was stained strongly on almost all regenerating muscle fibers. 1-syntrophin was stained weakly at the sarcolemma of some regenerating fibers on day 5, and by day 14 it was detected on all regenerating muscle fibers. In Western blot analysis, dystrophin (DYS1) and 1-syntrophin (1S) were completely absent on day 1. Re-expression of DYS1 and 1S was visible by day 5 and accelerated thereafter. The Western blots of DYS1 and 1S were densitometrically analyzed on each day. The protein levels on each day were converted to the percentage of the protein level on day 28, which was taken as 100%. From the sequential line based on these data, the following results were obtained on the chronological course of DYS1 and 1S. DYS1: 25% of the protein level on day 28 was reached by 3.5 days, 50% was reached by 5.3 days, and 90% was reached by 6.9 days. 1S: 25% of the protein level on day 28 was reached by 4.6 days, 50% was reached by 6.0 days, and 90% was reached by 12.5 days. In this study, DYS1 regenerated earlier than 1S at the sarcolemma of regenerating muscle fibers. 相似文献
15.
Journal of Muscle Research and Cell Motility - 相似文献
16.
Audrius Snieckus Sigitas Kamandulis Tomas Venckūnas Marius Brazaitis Gintautas Volungevičius Albertas Skurvydas 《European journal of applied physiology》2013,113(3):621-628
Here, we test the hypothesis that continuous concentric exercise training renders skeletal muscles more susceptible to damage in response to eccentric exercise. Elite road cyclists (CYC; n = 10, training experience 8.1 ± 2.0 years, age 22.9 ± 3.7 years), long-distance runners (LDR; n = 10, 9.9 ± 2.3 years, 24.4 ± 2.5 years), and healthy untrained (UT) men (n = 10; 22.4 ± 1.7 years) performed 100 submaximal eccentric contractions at constant angular velocity of 60° s?1. Concentric isokinetic peak torque, isometric maximal voluntary contraction (MVC), and electrically induced knee extension torque were measured at baseline and immediately and 48 h after an eccentric exercise bout. Muscle soreness was assessed and plasma creatine kinase (CK) activity was measured at baseline and 48 h after exercise. Voluntary and electrically stimulated knee extension torque reduction were significantly greater (p < 0.05) in UT than in LDR and CYC. Immediately and 48 h after exercise, MVC decreased by 32 % and 20 % in UT, 20 % and 5 % in LDR, and 25 % and 6 % in CYC. Electrically induced 20 Hz torque decreased at the same times by 61 and 29 % in UT, 40 and 17 % in LDR, and 26 and 14 % in CYC. Muscle soreness and plasma CK activity 48 h after exercise did not differ significantly between athletes and UT subjects. In conclusion, even though elite endurance athletes are more resistant to eccentric exercise-induced muscle damage than are UT people, stretch–shortening exercise-trained LDR have no advantage over concentrically trained CYC. 相似文献
17.
18.
Our aim is to describe the acute effects of catecholamines/β‐adrenergic agonists on contraction of non‐fatigued skeletal muscle in animals and humans, and explain the mechanisms involved. Adrenaline/β‐agonists (0.1–30 μm) generally augment peak force across animal species (positive inotropic effect) and abbreviate relaxation of slow‐twitch muscles (positive lusitropic effect). A peak force reduction also occurs in slow‐twitch muscles in some conditions. β2‐Adrenoceptor stimulation activates distinct cyclic AMP‐dependent protein kinases to phosphorylate multiple target proteins. β‐Agonists modulate sarcolemmal processes (increased resting membrane potential and action potential amplitude) via enhanced Na+–K+ pump and Na+–K+–2Cl− cotransporter function, but this does not increase force. Myofibrillar Ca2+ sensitivity and maximum Ca2+‐activated force are unchanged. All force potentiation involves amplified myoplasmic Ca2+ transients consequent to increased Ca2+ release from sarcoplasmic reticulum (SR). This unequivocally requires phosphorylation of SR Ca2+ release channels/ryanodine receptors (RyR1) which sensitize the Ca2+‐induced Ca2+ release mechanism. Enhanced trans‐sarcolemmal Ca2+ influx through phosphorylated voltage‐activated Ca2+ channels contributes to force potentiation in diaphragm and amphibian muscle, but not mammalian limb muscle. Phosphorylation of phospholamban increases SR Ca2+ pump activity in slow‐twitch fibres but does not augment force; this process accelerates relaxation and may depress force. Greater Ca2+ loading of SR may assist force potentiation in fast‐twitch muscle. Some human studies show no significant force potentiation which appears to be related to the β‐agonist concentration used. Indeed high‐dose β‐agonists (∼0.1 μm) enhance SR Ca2+‐release rates, maximum voluntary contraction strength and peak Wingate power in trained humans. The combined findings can explain how adrenaline/β‐agonists influence muscle performance during exercise/stress in humans.
IntroductionCatecholamines such as adrenaline (epinephrine) or noradrenaline (norepinephrine), released from the adrenal medulla or sympathetic nerves, can assist exercise performance through well‐known effects such as raised heart rate and myocardial contractility, bronchodilatation, electrolyte regulation, fuel mobilization and blood flow redistribution (Bowman, 1980; Zouhal et al. 2008; Roatta & Farina, 2010; Hostrup et al. 2014
a,b). In addition catecholamines, sympathetic nerve stimulation, or β‐adrenergic agonists can enhance the contractile performance of skeletal muscles of amphibia, animals and humans (for reviews see Bowman, 1980; Williams & Barnes, 1989
a; Roatta & Farina, 2010). Such effects on contractile function include a potentiation of peak force (positive inotropic effect) (Figs 1
A and C, ,33
B, and and44
C and D) and a faster relaxation of some muscles (positive lusitropic effect) (Fig. 1
A–C). However, in some situations a depression of peak force can occur (negative inotropic effect) (Fig. 1
B). The magnitude and nature of these adrenergic effects vary depending on such aspects as the fibre‐type composition of the muscle, species, concentration of agent, and the muscle condition, e.g. fatigued (Juel, 1988; Cairns & Dulhunty, 1994; Decorte et al. 2015) or K+ depressed (Clausen, 2003; Cairns et al. 2011). These effects all require activation of β2‐adrenergic receptors, since they manifest with general β‐adrenergic agonists, e.g. isoprenaline (isoproterenol), or selective β2‐adrenergic agonists such as salbutamol or terbutaline, i.e. short‐acting β2‐agonists, and are also antagonized with general or selective β2‐adrenoceptor blockers (Bowman, 1980). With the advent of long‐acting β2‐agonists, e.g. clenbuterol, some caution is needed about non‐selective effects especially when high concentrations are used (Head & Ha, 2011; McCormick et al. 2010), and their chronic application promotes muscle hypertrophy (Lynch & Ryall, 2008). The focus of the present article is on acute effects of catecholamines and short‐acting β‐agonists on cellular processes and contractile function of non‐fatigued skeletal muscle.Open in a separate windowFigure 1
Representative effects of terbutaline on isometric force or power in animal and human muscles
A, influence of terbutaline (10 μm for 15 min) on maximal tetanic contractions (100 Hz) in isolated rat slow‐twitch soleus fibre bundles. Supramaximal stimulation pulses delivered from parallel plate electrodes, 24°C. Reproduced from Cairns & Dulhunty, 1993
a with permission. B, influence of oral terbutaline (8 mg for 2 h+) compared with control (pre‐ingestion) on unfused tetanic contractions (10 Hz) in human soleus muscle in vivo. Stimulation of soleus muscle at body temperature (G. Crivelli, F. Borrani, R. Capt, G. Gremion & N. A. Maffiuletti, unpublished data). C, influence of inhaled terbutaline (15 mg for ∼20 min, plasma 24 ± 1 ng ml−1) compared with placebo on maximal voluntary contraction for quadriceps muscles in a trained human male. D, influence of inhaled terbutaline (15 mg for ∼30 min, plasma 24 ± 1 ng ml−1) compared with placebo on Wingate cycle power in a trained human male. C and D are reproduced from Hostrup et al. 2014
a with permission.Open in a separate windowFigure 3
Representative effects of 10 μm terbutaline on myoplasmic [Ca2+] ([Ca2+]i) and tension during tetanic stimulation (100 Hz) of single, intact fast‐twitch flexor digitorum brevis fibres of the mouse in vitro
[Ca2+]i was measured with the fluorescent Ca2+ indicator Indo‐1. ‘Terbutaline’ is the maximal effect obtained after 10 min terbutaline exposure. Parallel plate stimulation electrodes, 22°C. Adapted from Cairns et al. 1993 with permission.Open in a separate windowFigure 4
Influence of 10 μm isoprenaline on sarcoplasmic reticulum [Ca2+] ([Ca2+]SR) and cell shortening (i.e. fibre deflection) during twitch stimulation of fast‐twitch tibialis anterior fibres of the mouse in situ
[Ca2+]SR was measured with a cameleon Ca2+ sensor as the fluorescence ratio (F(535 nm)/F(450 nm)). Data are means ± SEM (25 individual twitches from 3 fibres). B and D were obtained 10 min after application of isoprenaline compared with before (control), i.e. A and C, respectively. Values are normalized to control. The positive inotropic effect is shown as the 50% increase in peak cell shortening (D). Reproduced from Rudolf et al. 2006 with permission (© 2006 Kim and Roy. Journal of Cell Biology. 173:187–193. doi:10.1083/jcb.200601160).Several reviews over the last 15 years have described β‐adrenergic effects on selected muscle processes (e.g. Catterall, 2000; Clausen, 2003; Lynch & Ryall, 2008; Capes et al. 2011) yet none have provided a wholistic appraisal of the β‐adrenergic mechanisms influencing muscle contraction since Williams & Barnes (1989
a). Moreover, a resurgence of studies on β‐adrenergic effects on human muscle (Table 2012; Roatta & Farina, 2013). Therefore, the aims of the present review are: (1) to provide a comprehensive update on the mechanisms underpinning β‐adrenergic effects on non‐fatigued skeletal muscle contraction in humans and animal models; and (2) to explain how adrenaline/β‐agonists influence muscle performance during exercise or stress in humans.
Open in a separate windowValues display the range of mean data from non‐fatigued muscles across the studies cited. ‐ ‐ ‐ ‐, no data reported. Drugs, applied as a bolus or continuous exposure, include adrenaline (Ad), noradrenaline (NAd), isoprenaline (Iso), salbutamol (Salb), terbutaline (Terb). Mammalian fast‐twitch muscles: tibialis anterior, extensor digitorum longus, gastrocnemius, diaphragm, sternomastoid, or flexor digitorum brevis. Mammalian slow‐twitch muscles: soleus, plantaris. Human muscles: quadriceps, triceps surae soleus, adductor pollicis. MVC, maximal isometric voluntary contraction, PPO, peak power output. Relaxation rate was determined for twitches or tetani using the maximum slope of force decline, or 1/relaxation time. References: (1) Arreola et al. 1987; (2) Gonzalez‐Serratos et al. 1981; (3) Oota & Nagai, 1977; (4) Williams & Barnes, 1989
b; (5) Al‐Jeboory & Marshall, 1978; (6) Andersson et al. 2012; (7) Bowman, 1980; (8) Bowman & Zaimis, 1958; (9) Bowman & Nott, 1970; (10) Cairns & Dulhunty, 1993
a; (11) Cairns et al. 1993; (12) Kӧssler et al. 1991; (13) McCormick et al. 2010; (14) Ha et al. 1999; (15) Slack et al. 1997; (16) Crivelli et al. 2013; (17) Crivelli & Maffiuletti, 2014; (18) Crivelli et al. 2011; (19) Marsden & Meadows, 1970; (20) Hostrup et al. 2014
a; (21) Hostrup et al. 2014
b; (22) Kalsen et al. 2013; (23) Collomp et al. 2005; (24) Le Panse et al. 2007 (25) Sanchez et al. 2012; (26) van Baak et al. 2000. Note: several studies with humans show non‐significant effects with β‐agonists, presumably due to low doses used, and are not indicated here (see Pluim et al. 2011 for references).
Table 1
Effects of catecholamines or β‐adrenergic agonists on skeletal muscle contraction across speciesPeak force | |||||
---|---|---|---|---|---|
Species | Drug (concentration) | Twitches | Unfused tetani | Maximal tetani | Relaxation rate |
Amphibia | Ad, Iso (1–30 μm) | ↑30–130% (Refs 1–4) | ‐ ‐ ‐ ‐ | ↔ (Refs 1,4) | ↑30–50% (Refs 2,4) |
Mammals Fast‐twitch | Ad, NAd, Iso, Salb, Terb (0.1–120 μm) | ↑7–51% (Refs 6–12) | ↑12–150% (Refs 5,7,8,10) | ↑7–20% (Refs 9,10,12) | ↔· or ↓7–11% (Refs 5–9) |
Slow‐twitch (cat, dog, rabbit, guinea‐pig) | Ad, NAd, Iso, Salb | ↓18–26% (Refs 7,8) | ↓20–60% (Refs 5,7–9,14) | ↔ or ↑3% (Refs 7,8 or 9) | ↑33% (Refs 5,7,8) |
Slow‐twitch (rat, mouse) | Ad, Iso, Salb, Terb (0.1–10 μm) | ↑15–52% (Refs 10,12–15) | ↑7–41% (Refs 10,14) | ↑7–29% (Refs 10,13) | ↑10–41% (Refs 10,14,15) |
Humans (isometrics) | Ad, Terb, Salb (6–8 or 15–20 mg) | ↔ or ↑11% (Refs 16–19 or 20) | ↓16–40% (Refs 16,17,19) | ↔ or ↑5–8% (MVC) (Refs 16–19 or 20–22) | ↑10–28% (Refs 16–20) |
(sprint cycling, isokinetics) | Salb or Terb (4–6 or 15–20 mg) | ‐ ‐ ‐ ‐ | ↑4–14% (Refs 23–26) | ↑2–14% (PPO) (Refs 21,23–25) | ‐ ‐ ‐ ‐ |
β‐Adrenergic effects on contraction
Peak force
Table 1987; Wolska et al. 1996; Li et al. 2000). Furthermore, peak tetanic force is amplified by up to 30% in isolated fast‐ and slow‐twitch muscles of rats and mice at room temperature (Figs 1 A and and33 B). In contrast, negative inotropic effects appear for submaximal isometric contractions of slow‐twitch soleus muscles of larger mammals in situ, and with unfused tetani in humans in vivo (Fig. 1 B). Whilst these contrasting effects seemingly involve fibre‐type or species differences, it is evident that both positive and negative inotropic effects can manifest in the same muscle. For example, prolonged exposure of isolated guinea‐pig soleus muscles to terbutaline (2.3 μm) induced a biphasic effect on peak twitch force with a 13% decline by 5 min which reversed into a 25% potentiation by 30 min (Holmberg & Waldeck, 1980). Also tetani evoked at >40 Hz are potentiated slightly in soleus muscles of the anaesthetized cat whereas unfused tetani are depressed (Bowman & Nott, 1970).With non‐asthmatic humans, exposure to therapeutic doses of adrenaline/β‐agonists (i.e. 800 μg to 8 mg) often have no effect on the peak twitch force of various muscles (Table 2012). Many studies show an unchanged maximum isometric voluntary contraction (MVC) strength with adrenaline/β‐agonists (Pluim et al. 2011), although the side‐effects of tremor, nausea or tachycardia (Marsden & Meadows, 1970; van Baak et al. 2000) may influence assessments involving voluntary contractions. However, recent studies with extremely high‐dose terbutaline (15–20 mg, ∼0.1 μm) (Fig. 1 C), or combined β‐agonists (Kalsen et al. 2013) show a 5–8% potentiation of the quadriceps MVC in athletes. Interestingly, β‐agonists also increase peak power during Wingate cycle tests (Fig. 1 D) by augmenting the peak force applied to the pedals (Table RelaxationTable 1 A and B), an effect detected with isoprenaline concentrations from 1 nm (Slack et al. 1997). With cardiac muscle the β‐adrenergic acceleration of twitch relaxation (Kurihara & Konishi, 1987; Wolska et al. 1996; Li et al. 2000) is at least double that for skeletal muscle (Table 3 B, and and44 C and D). With human muscles there is a faster relaxation for the quadriceps (Fig. 1 C) and soleus (Table 1970). We surmise that the speeding of relaxation with β‐agonists is a feature of slow‐twitch fibres in animal and human muscles.Mechanisms for β‐adrenergic effects on contraction
The positive inotropic effect for MVC strength in humans could, in principle, involve enhanced motor drive from the central nervous system, but this idea can be excluded since the voluntary activation ratio is unchanged with β‐agonists (Crivelli et al. 2011, 2013; Hostrup et al. 2014 b). Facilitation of either muscle blood flow (Zouhal et al. 2008) or events at the neuromuscular junction (Bowman, 1980) are not required for force potentiation since it transpires in directly stimulated muscle in vitro. Accordingly the mechanism must involve a modulation of muscle cell process(es).Cell signalling processes
To appreciate the mechanistic studies an understanding of the β2‐adrenergic signalling pathway is needed (Fig. 2). This involves activation of sarcolemmal β2‐adrenoceptors, coupled to stimulatory G‐proteins, which in turn activate adenylate cyclase to convert ATP to adenosine 3′,5′‐cyclic monophosphate (cAMP). This second messenger then activates several different cAMP‐dependent protein kinases (PKA) which phosphorylate target proteins to alter cell processes. Certainly, the finding that the β‐adrenergic potentiation of force requires 5–10 min for maximal effects in isolated single fibres (Gonzalez‐Serratos et al. 1981; Cairns et al. 1993) is coherent with formation and involvement of second messengers. A key feature is that myoplasmic cAMP ([cAMP]i) increases by 2‐ to 3‐fold in mammalian and human muscle with adrenaline/β‐agonists (Al‐Jeboory & Marshall, 1978; Chasiotis et al. 1983; Godinho & Costa, 2003; Rudolf et al. 2006). Notably, maximal [cAMP]i is attained only with β‐agonist concentrations of 10–50 μm (Al‐Jeboory & Marshall, 1978; Godinho & Costa, 2003), and this surpasses the physiological range (Harmer et al. 2000; Zouhal et al. 2008). The [cAMP]i reaches a peak in 5 min then declines by 20–60% over time due to extrusion from the cell (Chasiotis et al. 1983; Godinho & Costa, 2003; Rudolf et al. 2006; Duarte et al. 2012). With prolonged β‐agonist exposure the raised interstitial [cAMP] forms adenosine which may antagonize any positive inotropic effects (Duarte et al. 2012). Strong backing for an involvement of [cAMP]i comes from findings that extracellular application of membrane‐permeable analogues of cAMP, e.g. dibutyryl cAMP (DBcAMP) or 8‐bromo‐cAMP, exert positive inotropic effects in non‐fatigued amphibian (Oota & Nagai, 1977) or rodent muscles (Varagić & Kentera, 1978; Cairns & Dulhunty, 1993 a). Indeed, maximum increases of peak force or abbreviation of relaxation with DBcAMP quantitatively mimic that achieved with terbutaline in rat soleus (Cairns & Dulhunty, 1993 a). Interestingly, the slowly entering DBcAMP provokes an initial twitch depression which reverses into potentiation (Cairns & Dulhunty, 1993 a), as occurs with terbutaline (Holmberg & Waldeck, 1980). Hence the suggestion that lower [cAMP]i activates a force‐depressing process whilst higher [cAMP]i activates a force‐potentiating process.Open in a separate windowFigure 2 The β2‐adrenergic or cAMP–PKA signalling pathway for skeletal muscle fibres (Lynch & Ryall, 2008; Berdeaux & Stewart, 2012 ), together with several target proteins/processes that may influence contraction Common pharmacological tools used to explore this pathway are shown. AKAP, A‐kinase anchoring protein; cAMP, cyclic AMP; DBcAMP, dibutyryl‐cAMP; Gs, stimulatory guanine nucleotide binding protein; GTPγS, non‐hydrolysable analogue of guanosine triphosphate; NKCC, Na+–K+–2Cl− cotransporter; PKA, cAMP‐dependent protein kinase; RyR1, skeletal muscle ryanodine receptor; SR, sarcoplasmic reticulum; + stimulation; − inhibition. Target proteins are phosphorylated by PKA in intact fibres, membrane fragments or as isolated proteins (functional changes in parentheses). References for protein phosphorylation: (1) Bibert et al. 2008; (2) Wong et al. 2001; (3) Gosmanov & Thomason, 2002; (4) Yang & Barchi, 1990; (5) Emrick et al. 2010; (6) Johnson et al. 2005; (7) Mundina‐Weilenmann et al. 1991; (8) Liu et al. 1997; (9) Slack et al. 1997; (10) Anderson et al. 2012; (11) Hain et al. 1994; (12) Mayrleitner et al. 1995; (13) Reiken et al. 2003; (14) Suko et al. 1993; (15) Soderling et al. 1970.Cyclic AMP activates several different PKA which phosphorylate specific serine residues on multiple target proteins (some indicated in Fig. 2). Different PKA isoforms are localized in spatially distinct microdomains, such as near the sarcolemma or the transverse (t‐) tubular‐sarcoplasmic reticulum (SR) interface, which allows localized elevations of [cAMP]i (Rӧder et al. 2009). This compartmentalization is mediated by A‐kinase anchoring proteins (AKAPs) (Ruehr et al. 2003; Johnson et al. 2005; Emrick et al. 2010) and an intact actin cytoskeleton (Johnson et al. 2005; Rӧder et al. 2009), both of which influence the extent of phosphorylation and function of target proteins (Johnson et al. 1994; Ruehr et al. 2003). The cAMP‐dependent phosphorylation sites on target proteins are also influenced by Ca2+/calmodulin‐dependent protein kinases and phosphatases (Suko et al. 1993; Emrick et al. 2010). These target proteins exist as macromolecular complexes and incorporate several kinases and phosphatases (Marx et al. 2001; Capes et al. 2011) which could potentially influence the final cellular event. The abundance of phosphorylatable target proteins helps to explain why multiple processes are influenced by β‐agonists, as acknowledged long ago (Bowman, 1980). The next question involves determining which of the many target proteins/processes stimulated via the β‐adrenergic pathway (Fig. 2) specifically accounts for the modulation of contractile performance.Sarcolemmal processes
Catecholamines/β‐agonists are known to modulate at least two sarcolemmal ion transport processes in a manner that could potentially influence action potentials and force. Na+–K+ pump and Na+–K+–2Cl− cotransporter. The ion transport process best known to be stimulated by β‐agonists in skeletal muscle is the Na+–K+ pump (i.e. Na+–K+‐ATPase) (Clausen & Flatman, 1977; Juel, 1988; Clausen, 2003; Juel et al. 2014). Ouabain, an inhibitor of the Na+–K+ pump, antagonizes the ability of adrenaline, β‐agonists or DBcAMP to stimulate net Na+ efflux and K+ influx, lower intracellular [Na+] ([Na+]i), raise intracellular [K+] ([K+]i), and hyperpolarize the sarcolemma (Clausen & Flatman, 1977; McArdle & D''Alonzo, 1981; Clausen, 2003). The PKA‐mediated phosphorylation of phospholemman (FXYD1) (Fig. 2), a regulatory component of the Na+–K+ pump complex (Bibert et al. 2008; Bers & Despa, 2009), causes stimulation of pump activity by increasing its affinity for intracellular Na+ without changing the maximal pump transport (Clausen, 2003; Bibert et al. 2008). Details for this process have recently emerged (Bibert et al. 2008; Bers & Despa, 2009) showing that unphosphorylated FXYD1 inhibits Na+–K+ pump activity by reducing its affinity for intracellular Na+. β‐Adrenergic phosphorylation of FXYD1 subsequently releases this inhibition to increase Na+–K+ pump activity. Another process stimulated by adrenaline/β‐agonists is the Na+–K+–2Cl−‐cotransporter (NKCC) which contributes about one‐third of the isoprenaline (30 μm)‐induced K+ uptake in resting soleus and plantaris muscles of rats (Wong et al. 2001; Gosmanov & Thomason, 2002). This effect requires phosphorylation and activation of extracellular signal‐regulated kinase 1/2 and the mitogen‐activated protein kinase pathway (Gosmanov & Thomason, 2002). Various sarcolemmal ion channel activities may also be modulated (Bers & Despa, 2009). For example, the voltage‐activated Na+ channel, which is responsible for the upstroke of the action potential, is phosphorylated (Yang & Barchi, 1990), yet high concentrations of isoprenaline/DBcAMP inhibit maximal Na+ currents in rat fast‐twitch fibres (Desaphy et al. 1998). Resting membrane potential (E M) and action potentials. Adrenergic agents/DBcAMP hyperpolarize the sarcolemma of non‐fatigued rodent fibres with the resting E M increasing by 2–9 mV (Clausen & Flatman, 1977; McArdle & D''Alonzo, 1981; Juel, 1988; Cairns & Dulhunty, 1994). This occurs with adrenaline levels starting from 6 nm (Clausen & Flatman, 1977). This hyperpolarization appears to follow stimulation of the Na+–K+ pump but with a contribution from the NKCC. These processes raise [K+]i and lower interstitial [K+]o to increase the K+ equilibrium potential and, along with a greater electrogenic Na+–K+ pump current (Clausen, 2003), causes an increased resting E M. There are also reports showing that high concentrations of adrenaline/β‐agonists (0.5–50 μm) exert several positive effects on intracellularly recorded action potentials in rodent muscle. These include the overshoot increasing by 4–11 mV (McArdle & D''Alonzo, 1981; Head & Ha, 2011), the overshoot remaining higher within a brief train of action potentials (Head & Ha, 2011), the waveform broadening (McArdle & D''Alonzo, 1981; Head & Ha, 2011), and conduction velocity increasing (Kӧssler et al. 1991). Such effects are small and inconsistent in different mammalian muscle types when assessed using extracellular recordings of action potentials (M‐wave) (Bowman, 1980). Similarly, β‐agonists are without detectable effect on the surface M‐wave in human muscles (Marsden & Meadows, 1970; Crivelli et al. 2011, 2013; Crivelli & Maffiuletti, 2014). Our conclusion is that the muscle action potential can be influenced in a manner that could increase/maintain force at least in rodent muscles. The β‐agonist‐induced heightening of action potential overshoot occurs independently of changes to resting E M in non‐fatigued muscle (McArdle & D''Alonzo, 1981) but it may follow the Na+–K+ pump‐induced decline of [Na+]i since this elevates the Na+ equilibrium potential (McArdle & D''Alonzo, 1981; Juel, 1988).Despite these altered sarcolemmal processes neither the Na+–K+ pump nor NKCC contribute to the positive inotropic effect in non‐fatigued muscle. Terbutaline potentiates force when Na+–K+ pumps are blocked with ouabain in rat soleus (Cairns & Dulhunty, 1993 b) and any effect via altered action potential characteristics is discounted given that β‐agonists/DBcAMP augment submaximal K+ contractures (Oota & Nagai, 1977; Cairns & Dulhunty, 1993 b). K+ contractures involve bypassing action potentials to directly activate the voltage sensors of excitation–contraction (E–C) coupling (García et al. 1990; Avila et al. 2007). In fact, all force potentiation in non‐fatigued muscle is accounted for by processes stimulated beyond the action potential (Cairns & Dulhunty, 1993 b) which must include myofilament processes and/or E–C coupling processes. Nevertheless, β‐adrenergic modulation of sarcolemmal processes is important in other situations. For example, β‐agonists restore force in K+‐depressed muscle by stimulating the Na+–K+ pump to improve sarcolemmal excitability (Clausen, 2003; Cairns et al. 2011), and Na+–K+ pump stimulation may contribute to improved fatigue‐resistance in vitro (Juel, 1988).Myofilament processes
Two myofilament proteins are phosphorylated during β‐adrenoceptor activation in cardiac muscle, namely troponin‐I (which reduces myofilament Ca2+ sensitivity with less Ca2+ binding to troponin‐C), and C‐protein (which increases maximal crossbridge cycling) (Wolska et al. 1996; Gruen et al. 1999; Matsuba et al. 2009), but neither protein is phosphorylated in skeletal muscle (Stull & High, 1977; Gruen et al. 1999; Matsuba et al. 2009), nor is myosin light chain kinase (Manning & Stull, 1982). Functional testing for β‐adrenergic effects on myofilament processes requires investigation of the force–[Ca2+] relationship. Such experiments on intact fibres from fast‐twitch or slow‐twitch muscles from rodents show that terbutaline has no effect on myofibrillar Ca2+ sensitivity or maximum Ca2+‐activated force (reflecting maximum crossbridge activity) (Cairns et al. 1993; Ha et al. 1999). Other experiments on chemically skinned mammalian fibres (where only the contractile apparatus remains) confirm that there is an unchanged Ca2+ sensitivity and maximum Ca2+‐activated force with cAMP/PKA (Fabiato & Fabiato, 1978; Ha et al. 1999; Matsuba et al. 2009). Hence, in contrast to cardiac muscle, the β‐adrenergic effects on peak force or relaxation do not involve altered myofilament processes in skeletal muscle.Excitation–contraction coupling processes
The initial finding of a β‐adrenergic effect on intracellular Ca2+ transients was with terbutaline (10 μm) in single, intact fast‐twitch fibres from mice (Fig. 3 A) where peak myoplasmic [Ca2+] ([Ca2+]i) was augmented for unfused and maximal tetani (Cairns et al. 1993). The magnitude of this effect increased with higher stimulation frequencies. An increased peak tetanic [Ca2+]i was subsequently observed with terbutaline in slow‐twitch fibres from rats (Ha et al. 1999) and in frog twitch fibres (Bruton et al. 1996). Moreover, an increased peak twitch [Ca2+]i occurs in rodent hindlimb fibres with β‐agonists (Ha et al. 1999; Prakash et al. 1999; Andersson et al. 2012) or DBcAMP (Liu et al. 1997; Prakash et al. 1999). Notably, a basal level of phosphorylation had already augmented peak twitch [Ca2+]i and restricted the effects of further phosphorylation with DBcAMP (Liu et al. 1997). This indicates that several phosphorylation processes can influence Ca2+ transients. The increase of peak [Ca2+]i in these studies on isolated rodent muscle fibres at room temperature was typically 20–35% initial which is somewhat less than for cardiac muscle where the magnitude depends on the extracellular [Ca2+] (Kurihara & Konishi, 1987; Wolska et al. 1996; Li et al. 2000). Concentration–response effects have only been studied in myocytes from neonatal limb muscles where peak twitch [Ca2+]i was increased with salbutamol concentrations over 10–100 nm (Prakash et al. 1999). Furthermore, an elegant study by Rudolf et al. (2006) made important progress by showing directly that isoprenaline (10 μm) facilitated the emptying of Ca2+ from the SR of mouse tibialis anterior muscle in situ (Fig. 4 A and B), and this effect was greater with tetanic than twitch stimulation. Thus the increased Ca2+ transient amplitude involves greater Ca2+ efflux from the SR and can occur at body temperature.A key finding is that terbutaline simultaneously increases peak [Ca2+]i and force (Fig. 3) in a manner which causes an upwards shift along the force–[Ca2+]i relationship (Cairns et al. 1993; Ha et al. 1999). This establishes that the positive inotropic effect is fully accounted for by a modulation of processes involved with E–C coupling. Based on phosphorylation studies (Fig. 2) we envisioned that the β‐adrenergic effects on Ca2+ handling may comprise the following proteins: (1) the voltage‐activated Ca2+ channel (i.e. L‐type/Cav1.1 channel, dihydropyridine receptor, DHPR) located in t‐tubular membranes; (2) phospholamban (PLB), a protein associated with the SR Ca2+ pump (i.e. Ca2+‐ATPase, SERCA2); and/or (3) the Ca2+ release channel/ryanodine receptor of the terminal cisternae of SR (i.e. RyR1 isoform). Voltage‐activated Ca 2 +‐channels and trans‐sarcolemmal Ca 2 + influx. β‐Adrenergic modulation of the DHPR may entail greater charge movement – the signal arising from the DHPR as the voltage sensor for E–C coupling (García et al. 1990; Avila et al. 2007) and/or enhanced Ca2+ influx to either trigger further Ca2+ release from the SR or load the SR with Ca2+ for subsequent release. The first possibility is discounted since neither isoprenaline nor PKA increase charge movement (García et al. 1990) but a boosted Ca2+ influx seems feasible. Indeed, β‐agonists/PKA amplify slow Ca2+ currents in amphibian (Arreola et al. 1987; García et al. 1990) and rodent fibres (García et al. 1990; Johnson et al. 1994, 2005). Moreover, PKA‐induced phosphorylation of the DHPR shifts the voltage dependence of channel activation during repetitive depolarizations to more negative E M, which considerably magnifies the Ca2+ influx (Johnson et al. 1994, 2005). It seems plausible that this phenomenon occurs during tetanic stimulation. Such trans‐sarcolemmal Ca2+ influx does not directly increase the Ca2+ transient (Rudolf et al. 2006) but may lead to increased Ca2+ release from SR. Single DHPR channel recordings divulge that PKA elicits an increased channel open time, a leftwards shift in voltage dependence of activation, a decreased rate of inactivation and an increased channel availability (Mundiña‐Weilenmann et al. 1991). These combined actions adequately explain the amplified macroscopic Ca2+ current. Interestingly, it appears that PKA exerts greater facilitation of Ca2+ currents in amphibian than in mammalian fibres (García et al. 1990), and stimulates an additional small but fast Ca2+ current in amphibian fibres (Arreola et al. 1987). β‐Agonists also elevate resting [Ca2+]i in amphibian fibres (Bruton et al. 1996), which is indicative of Ca2+ influx, but not in mammalian fibres (Cairns et al. 1993; Liu et al. 1997; Ha et al. 1999; Prakash et al. 1999). A third proposal is that phosphorylation of the DHPR results in a protein–protein interaction with the RyR1 to potentiate Ca2+ release, and this idea has some but not extensive backing (Lu et al. 1995).An enhanced trans‐sarcolemmal Ca2+ influx is crucial for the β‐adrenergic potentiation of cardiac twitches (Kurihara & Konishi, 1987; Li et al. 2000; Bers & Despa, 2009), but its importance for skeletal muscle varies between muscles. First, Ca2+ channel blockers antagonize the β‐adrenergic potentiation of force in amphibian fibres (Williams & Barnes, 1989 b) and rat diaphragm (Varagić & Kentera, 1978; Todorović et al. 2006), but not in rat limb muscle (Cairns & Dulhunty, 1993 b). Also, the positive inotropic effect is magnified in the presence of Ca2+ ionophores in rat diaphragm (Varagić et al. 1979). Second, the β‐adrenergic force potentiation is abolished or attenuated with Ca2+‐free solutions in amphibian fibres (Arreola et al. 1987; Williams & Barnes, 1989 b) or rat diaphragm (Varagić & Kentera, 1978, Varagić et al. 1979). Third, in quiescent muscles, when sarcolemmal DHPR channels remain closed, the force potentiation is abolished in amphibian fibres (Arreola et al. 1987; Williams & Barnes, 1989 b) but is well developed in mouse fast‐twitch fibres (Cairns et al. 1993; Rudolf et al. 2006). Hence a trans‐sarcolemmal Ca2+ influx is likely to contribute to force potentiation in diaphragm and amphibian fibres, but not in mammalian limb muscles. Phospholamban and SR Ca 2 + uptake. A larger Ca2+ transient may involve phosphorylation of PLB, which stimulates Ca2+ uptake into SR for subsequent release in cardiac muscle (Wolska et al. 1996; Li et al. 2000; Bers & Despa, 2009). However, PLB exists only in the SR of slow‐twitch and not fast‐twitch mammalian muscle (Liu et al. 1997; Vangheluwe et al. 2005) and phosphorylated PLB only increases the Ca2+ uptake rate for SR vesicles from slow‐twitch fibres of mammals (Kirchberger & Tada, 1976) and humans (Salviati et al. 1982). Mechanistic work (Song et al. 2004; Bibert et al. 2008; Bers & Despa, 2009) shows that unphosphorylated PLB inhibits the Ca2+ pump by lowering its affinity for Ca2+. Phosphorylation of PLB then reverses this inhibition to increase Ca2+ activation of the pump. Crucial observations relating to contraction are that β‐agonists/DBcAMP potentiate force and increase the amplitude of Ca2+ transients in fast‐twitch fibres and soleus fibres knockout for PLB (Cairns et al. 1993; Liu et al. 1997). Also the isoprenaline‐induced twitch potentiation is identical in soleus muscles that are wild‐type, overexpressing PLB (Song et al. 2004), or knockout for PLB (Slack et al. 1997). These combined findings confirm that the β‐adrenergic potentiation of force is not mediated via PLB in skeletal muscle.An alternative hypothesis is that enhanced Ca2+ loading of SR occurs independently of PLB. However, maximal Ca2+ loading is unchanged with terbutaline/PKA in skinned slow‐twitch fibres from rats or humans (Salviati et al. 1982; Ha et al. 1999). In contrast, a raised basal [Ca2+]SR has recently been shown with isoprenaline in mouse tibialis anterior muscle which seems to account for much of the increased Ca2+ release (Fig. 4 A and B). A similar Ca2+‐loading effect was inferred long ago for cat fast‐twitch caudofemoralis fibres that were chemically skinned and exposed to cAMP (Fabiato & Fabiato, 1978), and for split frog fibres (Gonzalez‐Serratos et al. 1981). Increased SR Ca2+ loading in fast‐twitch fibres does not involve PLB but may require phosphorylation of a 95 kDa protein, which could be the Ca2+ pump itself (Schwartz et al. 1976). Interestingly, phosphorylase kinase increases Ca2+ pump activity (Schwartz et al. 1976), which implies that the well‐known β‐adrenergic stimulation of muscle glycogenolysis/glycolysis (Chasiotis et al. 1983; Hostrup et al. 2014 b) may be intricately linked to SR Ca2+ loading (Schwartz et al. 1976). A role for this process in the positive inotropic effect in fast‐twitch muscle appears plausible but needs greater experimental support.The β‐adrenergic phosphorylation of PLB is, nevertheless, functionally important since it is postulated to mediate the faster relaxation in slow‐twitch fibres, as in cardiac muscle (Wolska et al. 1996; Li et al. 2000). β‐Agonist exposure to slow‐twitch or transgenic muscles overexpressing PLB abbreviates relaxation (Cairns & Dulhunty, 1993 a; Ha et al. 1999; Song et al. 2004), whereas this positive lusitropic effect does not happen when PLB is absent (Cairns & Dulhunty, 1993 a; Slack et al. 1997). Furthermore, in soleus fibres with PLB present β‐agonists/DBcAMP accelerate the decline of Ca2+ transients (Liu et al. 1997; Ha et al. 1999) and PKA accelerates SR Ca2+ uptake (Kirchberger & Tada, 1976). Similar enhanced Ca2+ sequestering effects occur in SR from human quadriceps muscle after terbutaline exposure (Hostrup et al. 2014 b). In contrast, the rate of decline of [Ca2+]i is unaltered in mouse fibres lacking PLB (Cairns et al. 1993; Liu et al. 1997). Taken together, it seems that the PKA‐induced phosphorylation of PLB stimulates the Ca2+ pump to enhance Ca2+ uptake into SR, speeds the decline of the Ca2+ transient, and hence abbreviates relaxation in slow‐twitch fibres.The negative inotropic effect with β‐agonists is most apparent with unfused tetani in slow‐twitch muscles of larger mammals and humans (Fig. 1 B, Table 1958; Bowman & Nott, 1970; Al‐Jeboory & Marshall, 1978). Hence it is tempting to speculate that the force depression may be due to phosphorylation of PLB and greater SR Ca2+ pumping. This effect potentially lowers the amplitude of the Ca2+ transient which depends on the rates of both SR Ca2+ release and uptake. The mechanical expression of cAMP could well hinge on the relative contributions from phosphorylated PLB (on SR Ca2+ pump) and those processes that stimulate SR Ca2+ release (Ha et al. 1999). In line with this idea the β‐adrenergic depression of force is often absent in rat and mouse soleus muscles (Table 2005). This feature may permit the β‐adrenergic processes which augment force to dominate. Ca 2 + release channel and SR Ca 2 + release. The β‐adrenergic facilitation of Ca2+ release may involve modulation of the SR Ca2+ release channel/ryanodine receptor (i.e. RyR1 isoform), as discussed for cardiac muscle (Capes et al. 2011). This could occur indirectly via provision of ATP, consequent to stimulation of glycogenolysis/glycolysis (Chasiotis et al. 1983; Hostrup et al. 2014 b), since ATP modulates RyR1 channel activity (Sonnleitner et al. 1997). However, the β‐adrenergic force potentiation endures in the presence of iodoactetate, which blocks glycolysis (Cairns & Dulhunty, 1993 b), thus negating this possibility. A scenario, with mounting experimental support, is that PKA phosphorylates and directly modulates the RyR1 channel. First, Meissner (1984) showed that cAMP enhances the rate of Ca2+ efflux from isolated SR vesicles from rabbit muscle via the so‐called Ca2+‐induced Ca2+ release mechanism. Second, forskolin, which increases [cAMP]i (Fig. 2), stimulates Ca2+‐induced Ca2+ release in cells when AKAP is colocalized with RyR1 (Ruehr et al. 2003). Third, pretreatment with either caffeine or ryanodine, which act on the RyR1, antagonizes the salbutamol‐induced potentiation of Ca2+ transients in myocytes (Prakash et al. 1999). Fourth, Andersson et al. (2012) have now provided water‐tight evidence that the isoprenaline‐induced increase of peak twitch [Ca2+]i in mouse fast‐twitch fibres requires RyR1 phosphorylation. They exchanged the serine phosphorylation site on RyR1 with alanine, which cannot be phosphorylated, with the outcome being that isoprenaline no longer augmented the Ca2+ transient. Fifth, key findings on animal muscles have now been extended to human muscles, with the RyR1 being phosphorylated (Marx et al. 2001). Also Hostrup et al. (2014 b) showed that high‐dose terbutaline induced a 15% increase in SR Ca2+ release rate in homogenates from human quadriceps muscle. Hence it is undeniable that the β‐adrenergic effects on SR Ca2+ handling seen in animals also occur in humans, and it involves modulation of the RyR1.Details of the mechanism by which PKA regulates skeletal muscle RyR1 function have been developed from studies on isolated RyR1 and single channel currents. Phosphorylation of the RyR1 facilitates Ca2+ release (gated by Ca2+) by making the RyR1 channel insensitive to block with Mg2+ (Hain et al. 1994; Mayrleitner et al. 1995). In addition, PKA enhances RyR1 Ca2+ currents that are gated by ATP in the absence of Ca2+ (Sonnleitner et al. 1997). The RyR1 macromolecular protein complex incorporates PKA and a regulatory FK‐506 binding protein (FKBP12) which stabilizes the RyR1 channel in its closed state (Reiken et al. 2003). Phosphorylation of the RyR1 stimulates its channel activity (gated by Ca2+) by releasing FKBP12 which increases the probability of RyR1 channel opening, whilst decreasing open and closed dwell times (Reiken et al. 2003).The β‐adrenergic effects via the RyR1 appear intimately linked to force potentiation. Caffeine pretreatment abolishes the β‐adrenergic increase of both peak force (Cairns & Dulhunty, 1993 b) and peak [Ca2+]i (Prakash et al. 1999), which vindicates the RyR1 in these effects. However, it is the well‐conceived and sophisticated experiments of Andersson et al. (2012) which provide unequivocal support for a modulatory role of the RyR1 since both the isoprenaline‐induced phosphorylation of the RyR1 and twitch potentiation were abolished in mouse fast‐twitch muscle when the serine phosphorylation site on the RyR1 was replaced with alanine. Summary. The β‐adrenergic elevation of peak twitch [Ca2+]i necessitates phosphorylation of the RyR1 to enhance SR Ca2+ release, presumably by sensitizing the Ca2+‐induced Ca2+ release mechanism. This process is also likely to increase peak tetanic [Ca2+]i with contributions from trans‐sarcolemmal Ca2+ influx or Ca2+ loading of SR independently of PLB also being possible. The location on the sigmoidal force–[Ca2+]i relationship determines the extent of the β‐adrenergic force potentiation. Small increases of peak [Ca2+]i promote larger force increments when on the steep part of this relationship as for unfused tetani, and large increases of peak [Ca2+]i cause smaller force increases when troponin nears saturation with Ca2+, as for maximal tetani.Influence of catecholamines/β‐agonists during exercise or stress
Endogenous catecholamines
In order to understand the role of catecholamines released from the adrenal medulla or sympathetic nerves on human muscle performance it is imperative to know the catecholamine concentrations that muscles are exposed to. Plasma catecholamine levels increase with the intensity and duration of exercise (Zouhal et al. 2008) so that during maximal aerobic exercise the concentration of noradrenaline is 4–5 times greater than for adrenaline, i.e. ∼10 nm versus 2 nm, respectively (Zouhal et al. 2008). With supramaximal exercise these concentrations are exceeded with noradrenaline reaching 10–20 nm and adrenaline 5–10 nm (Harmer et al. 2000; Zouhal et al. 2008). Since both catecholamines bind to β2‐adrenoceptors, a combined concentration of 30 nm could be regarded as an extreme physiological level for exercise. Given that the fight‐or‐flight or stress response has been equated to an adrenergic response the catecholamine levels in some stressful scenarios were identified. With risky sports, such as rock climbing or high ropes events, the adrenaline/noradrenaline levels reach 2–5 nm (Williams et al. 1978; Bunting & Gibbons, 2001) and slightly lower levels are achieved during laboratory stress testing (Bunting & Gibbons, 2001). Such catecholamine concentrations during exercise or stress would probably evoke submaximal [cAMP]i (Al‐Jeboory & Marshall, 1978; Godinho & Costa, 2003) and therefore cause submaximal stimulation of glycogenolysis, the Na+–K+ pump or SR Ca2+ pump (Clausen & Flatman, 1977; Chasiotis et al. 1983; Slack et al. 1997). This information concurs with the view of Roatta & Farina (2013) that stress would not induce an increase of force, since the highest catecholamine levels achieved during stress (i.e. 5 nm) are unlikely to potentiate Ca2+ transients (Prakash et al. 1999) and evoke positive inotropic effects. However, the highest catecholamine concentrations during exercise (i.e. 30 nm) may facilitate some Ca2+ release (Prakash et al. 1999) to increase force. This information also implies that other endogenous physiological agents which elevate [cAMP]i, such as calcitonin gene‐related peptide (CGRP) (Clausen, 2003; Avila et al. 2007; Rӧder et al. 2009), may act synergistically with catecholamines to improve muscle function, and this idea warrants further study.Exogenous β‐agonists
Several studies with β‐agonists in humans show increased muscle force/power (Fig. 1 C and D), yet other studies are without significant effect (see Pluim et al. 2011). These inconsistencies can be explained if the β‐agonist concentrations are too low to permit significant positive inotropic effects. Certainly, a common therapeutic dose (8 mg) yields median plasma concentrations of 11–16 ng ml−1, i.e. 60–90 nm (Elers et al. 2012), and with high individual variability (Elers et al. 2012). Plasma concentrations also generally peak 60–180 min after ingestion (Elers et al. 2012), which is when [cAMP]i has presumably fallen due to extrusion from muscle (Chasiotis et al. 1983; Godinho & Costa, 2003; Rudolf et al. 2006) and this may attenuate β‐adrenergic effects. Hostrup and colleagues (2014 a,b) have now essentially resolved this issue by showing that very high‐dose terbutaline (15–20 mg, plasma concentration 17–22 ng ml, 0.08–0.1 μm), whether administered orally or nasally, does significantly augment quadriceps MVC strength. Although this 0.1 μm is much lower than the 1–10 μm used to potentiate SR Ca2+ release and force in animals (Table 1999) and actually does increase the SR Ca2+ release rate in humans (Hostrup et al. 2014 b). In addition, the endogenous phosphorylation of RyR1 (Hain et al. 1994; Liu et al. 1997) may limit the degree of further phosphorylation with exogenous β‐agonists (Liu et al. 1997) to mask or limit improvements to performance. During exercise any effect of β‐agonists will necessarily be superimposed on those of circulating catecholamines, and a basal phosphorylation of the RyR1 is also likely to occur with CGRP or Ca2+–calmodulin (Suko et al. 1993; Mayrleitner et al. 1995). Indeed CGRP can increase SR [Ca2+]i release in some conditions (Avila et al. 2007). Greater understanding of the processes contributing to basal phosphorylation of human muscle in vivo is needed.Conclusions and perspectives
β‐Agonists exert positive inotropic effects in human and animal skeletal muscle, but only when the concentrations are high enough. The cAMP–PKA pathway with lower [cAMP]i stimulates muscle glycogenolysis, the Na+–K+ pump and SR Ca2+ pump, during exercise and stressful situations. The cellular machinery and mechanisms which enhance SR Ca2+ release to increase force/power are present in human muscle, but need to be activated with higher [cAMP]i as occurs with very high β‐agonist concentrations. The β‐adrenergic processes which regulate SR Ca2+ handling are still not fully understood. More experiments and knowledge are needed on concentration–response relationships for many E–C coupling processes, including RyR1 function, Ca2+ loading of SR, trans‐sarcolemmal Ca2+ currents, and DHPR–RyR1 interactions. Studies on β‐adrenergic effects in human muscle tissue in vitro may provide enlightenment. Finally, experiments are needed on myoplasmic Ca2+ transients in relation to the negative inotropic effect seen in some slow‐twitch muscles. 相似文献19.
Eric D. Ryan Trent J. Herda Pablo B. Costa Ashley A. Walter Katherine M. Hoge Jeffery R. Stout Joel T. Cramer 《European journal of applied physiology》2010,108(1):207-211
The purposes of the present study were to (1) characterize viscoelastic creep in vivo in the human skeletal muscle–tendon unit and (2) to examine the consistency of these responses during a single 30-s stretch. Twelve volunteers (mean ± SD = 22 ± 3 years; height = 169 ± 11 cm; mass = 70 ± 17 kg) participated in two separate experimental trials. Each trial consisted of a 30-s constant-torque stretch of the plantar flexor muscles. Position (°) values were quantified at every 5-s period (0, 5, 10, 15, 20, 25, and 30 s) and the percent change in position was quantified for each 5-s epoch (0–5, 5–10, 10–15, 15–20, 20–25, and 25–30 s) relative to the total increase in the range of motion. In addition, the intraclass correlation coefficient (ICC) and standard errors of the measurement (SEM) were calculated for test–retest reliability. These results indicated that position increased over the entire 30-s stretch (P < 0.05), while the majority of the increases in position (73–85%) occurred during the first 15–20 s. ICC values were >0.994 and SEM values (expressed as percentage of the mean) were <1.54%. In conclusion, these results demonstrate viscoelastic creep in vivo in the human skeletal muscle–tendon unit and suggest that these responses may be reliable for future studies. 相似文献
20.